Exposure to ACE inhibitors prior to the onset of scleroderma renal crisis-results from the international scleroderma renal crisis survey

Marie Hudson, Murray Baron, Solène Tatibouet, Daniel E. Furst, Dinesh Khanna, Laura Hummers, Eric Hachulla, Thomas Medsger, Virginia Steen, Firas Alkassab, Sindhu Johnson, Oyvind Midtvedt, Gabriella Szucs, Elena Schiopu, Patricia E. Carreira, Chris T. Derk, Oliver Distler, Murat Inanc, Nader Khalidi, Tafazzul H. MahmudMaureen D. Mayes, Kevin McKown, Susanna Proudman, Lidia Rudnicka, Stuart Seigel, Jack Stein, Gabriele Valentini, Sule Yavuz, Hector Arbillaga, Beth Hazel, Jan Schulz, Milton Baker, Mike Becker, Jean Cabane, Andrew Chow, Romy Christmann, Philip Clements, Mary Ellen Csuka, Katharina Hanke, Ina Kötter, Soren Jacobsen, Jason Kur, Edward V. Lally, Sophie Ligier, Shikha Mittoo, Christine Peschken, Paloma Garcia De La Pena-Lefebvre, Viviane Queyrel, Richard Silver, Robert Simms, Klaus Sondergaard, Yves Troyanov, Maria C. Turi, John Varga, Panayiotis G. Vlachoyiannopoulos, Alexandre E. Voskuyl, Carol Yeadon, Rene Westhovens

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Exposure to ACE inhibitors prior to the onset of scleroderma renal crisis-results from the international scleroderma renal crisis survey'. Together they form a unique fingerprint.

Medicine & Life Sciences